Cargando…

Efficacy of Teriparatide in Patients with Hypoparathyroidism: A Prospective, Open-label Study

CONTEXT: Conventional treatment of hypoparathyroidism with calcium, Vitamin D analogs, and thiazide diuretics is often suboptimal, and these patients have poor quality of life. Teriparatide (parathyroid hormone 1–34 [PTH (1–34)]), an amide of PTH, is widely available for the use in osteoporosis; how...

Descripción completa

Detalles Bibliográficos
Autores principales:	Upreti, Vimal, Somani, Shrikant, Kotwal, Narendra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434725/ https://www.ncbi.nlm.nih.gov/pubmed/28553597 http://dx.doi.org/10.4103/ijem.IJEM_340_16

Ejemplares similares

Chronic hypoparathyroidism and treatment with teriparatide
por: Marcucci, Gemma, et al.
Publicado: (2021)

A randomized, controlled trial comparing the metformin, oral contraceptive pills and their combination in patients with polycystic ovarian syndrome
por: Kumar, Yogesh, et al.
Publicado: (2018)

A Prospective, Observational Study of Osteoporosis in Men
por: Kotwal, Narendra, et al.
Publicado: (2018)

Continuous Teriparatide Treatment in Chronic Hypoparathyroidism: A Case Report
por: Saraiva, Miguel, et al.
Publicado: (2021)

Effect of Glycemic Variability on Mortality in ICU Settings: A Prospective Observational Study
por: Singh, Manjitpal, et al.
Publicado: (2018)

Liraglutide as an Alternative to Insulin for Glycemic Control in Intensive Care Unit: A Randomized, Open-label, Clinical Study
por: Verma, Vishesh, et al.
Publicado: (2017)

Hypopituitarism following rifle cleaning accident
por: Upreti, Vimal, et al.
Publicado: (2016)

Safety and Efficacy of Oral Human Parathyroid Hormone (1‐34) in Hypoparathyroidism: An Open‐Label Study
por: Ish‐Shalom, Sofia, et al.
Publicado: (2021)

Effect of Antithyroid Therapies on Bone and Body Composition: A Prospective, Randomized, Clinical Study Comparing Antithyroid Drugs with Radioiodine Therapy
por: Kansara, Shekhar, et al.
Publicado: (2017)

Association of Vitamin D and Parathyroid Hormone with Insulin Sensitivity, Beta Cell Function and Gestational Diabetes in Pregnancy: A Cross-Sectional, Observational Study
por: Nachankar, Amit, et al.
Publicado: (2018)

Teriparatide Replacement Therapy for Hypoparathyroidism During Treatment With Lenvatinib for Advanced Thyroid Cancer: A Case Report
por: Porcelli, Tommaso, et al.
Publicado: (2018)

Intermittent Bi-Daily Sub-cutaneous Teriparatide Administration in Children With Hypoparathyroidism: A Single-Center Experience
por: Bernardor, Julie, et al.
Publicado: (2021)

Bilateral inferior petrosal sinus sampling using vasopressin
por: Kotwal, Narendra, et al.
Publicado: (2016)

Off-Label Use of Teriparatide in Spine
por: Drakopoulos, Panagiotis, et al.
Publicado: (2021)

Efficacy of generic teriparatide and alendronate in Chinese postmenopausal women with osteoporosis: a prospective study
por: Li, Mei, et al.
Publicado: (2022)

Thyrotoxic periodic paralysis: A retrospective, observational study from India
por: Verma, Vishesh, et al.
Publicado: (2020)

SUN-517 Postoperative Hypoparathyroidism Treated With Teriparatide In Apatient With Malabsorption Due To Celiac Disease: A Case Report And Literature Review
por: Khan, Mehr, et al.
Publicado: (2019)

An open-label, prospective, multicenter, clinical study to evaluate efficacy of Ayuartis capsules in patients suffering from osteoarthritis of the knee(s)
por: Mundhe, Narendra B., et al.
Publicado: (2019)

24-Month Open-Label Teriparatide Once-Weekly Efficacy Research Trial Examining Bone Mineral Density in Subjects with Primary Osteoporosis and High Fracture Risk
por: Sugimoto, Toshitsugu, et al.
Publicado: (2017)

Impact of patient background factors on the treatment efficacy of once-weekly teriparatide
por: Omura, Fumitoshi
Publicado: (2019)

Update on the safety and efficacy of teriparatide in the treatment of osteoporosis
por: Minisola, Salvatore, et al.
Publicado: (2019)

Improvement in Glucocorticoid-Induced Osteoporosis on Switching from Bisphosphonates to Once-Weekly Teriparatide: A Randomized Open-Label Trial
por: Nanki, Toshihiro, et al.
Publicado: (2022)

Assessing the Patient Experience of Hypoparathyroidism Symptoms: Development of the Hypoparathyroidism Patient Experience Scale-Symptom (HPES-Symptom)
por: Brod, Meryl, et al.
Publicado: (2019)

THU434 A Case Of An Atypical Femur Fracture Managed Medically With Teriparatide
por: Rupani, Sawan V, et al.
Publicado: (2023)

Effects of teriparatide in Chinese and Caucasian women with osteoporosis: bridging study on efficacy
por: Xie, Zhongjian, et al.
Publicado: (2019)

Estimation of magnesium in patients with functional hypoparathyroidism
por: Kannan, Subramanian, et al.
Publicado: (2014)

Study of twice-weekly injections of Teriparatide by comparing efficacy with once-weekly injections in osteoporosis patients: the TWICE study
por: Sugimoto, T., et al.
Publicado: (2019)

Living with hypoparathyroidism: development of the Hypoparathyroidism Patient Experience Scale-Impact (HPES-Impact)
por: Brod, Meryl, et al.
Publicado: (2020)

Hypoparathyroidism: An Uncommon Complication Associated With Immune Checkpoint Inhibitor Therapy
por: El Kawkgi, Omar M., et al.
Publicado: (2020)

Teriparatide in the management of osteoporosis
por: Bodenner, Donald, et al.
Publicado: (2007)

Review of Hypoparathyroidism
por: Abate, Ejigayehu G., et al.
Publicado: (2017)

OR23-05 Log-term Efficacy And Safety Of Transcon PTH In Adults With Hypoparathyroidism: 52-week Results From The Open-label Extension Of The Phase 3 Pathway Trial
por: Clarke, Bart, et al.
Publicado: (2023)

Safety and Efficacy of PTH 1‐34 and 1‐84 Therapy in Chronic Hypoparathyroidism: A Meta‐Analysis of Prospective Trials
por: Puliani, Giulia, et al.
Publicado: (2022)

Efficacy of quetiapine in patients with bipolar I and II depression: a multicenter, prospective, open-label, observational study
por: Jeong, Jong-Hyun, et al.
Publicado: (2013)

Efficacy and Safety of Esaxerenone in Hypertensive Patients with Diabetic Kidney Disease: A Multicenter, Open-Label, Prospective Study
por: Uchida, Haruhito A., et al.
Publicado: (2022)

Teriparatide and Osteosarcoma Risk: History, Science, Elimination of Boxed Warning, and Other Label Updates
por: Krege, John H, et al.
Publicado: (2022)

Under-recognized Hypoparathyroidism in Thalassemia
por: Tangngam, Hataitip, et al.
Publicado: (2018)

Treatment of Atypical Fracture of the Ulnar Diaphysis by Open Reduction and Internal Fixation with Teriparatide
por: Ito, Hiroki, et al.
Publicado: (2019)

TransCon PTH as a Hormone Replacement Therapy for Patients with Hypoparathyroidism: 6-Month Update from the PaTH Forward Open-Label Extension
por: Rubin, Mishaela R, et al.
Publicado: (2021)

Efficacy of once-weekly and twice-weekly injections of teriparatide by patient characteristics: A post hoc analysis of the TWICE study
por: Sugimoto, Toshitsugu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k8an5kjvieo14v0kagu7018bak